News
“Further tightening of an already strict program would likely worsen outcomes,” new report says.
The IPO market is at its hottest point in years,…
Here are the main takeaways culled from conversations and research…
aluxum/E+ via Getty ImagesAltimmune (NASDAQ:ALT) shares rose on Tuesday after the company reported promising Q2…
“When a brand sees momentum stall so sharply, it often reflects a reputational or cultural…
Bullish is set to go public in the coming days, and is expected to be…
ZIM Integrated take private may be difficult – analyst
A key measure of consumer prices in July posted the biggest increase in six months,…
IM Cannabis GAAP EPS of $0.09, revenue of $12.7M